Miles Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$441K Buy
1,944
+47
+2% +$12.8K 0.48% 59
2019
Q4
$573K Sell
1,897
-30
-2% -$8.26K 0.46% 62
2019
Q3
$463K Buy
+1,927
New +$528K 0.38% 75
2015
Q4
Sell
-5,900
Closed -$826K 171
2015
Q3
$826K Sell
5,900
-66
-1% -$9.92K 0.59% 35
2015
Q2
$979K Buy
5,966
+2,759
+86% +$441K 0.64% 36
2015
Q1
$495K Buy
+3,207
New +$457K 0.29% 84

Other funds holding ELV

Miles Capital's ELV Position: Q1 2020 in Review

Miles Capital increased its Elevance Health (ELV) stake by 2.5% in Q1 2020, buying an estimated $12.8K and bringing the position to 1,944 shares worth $441K. The position accounts for 0.48% of the portfolio, ranked #59.

Miles Capital first reported a position in ELV in Q1 2015 and has held it in 6 quarters since. The position peaked at $979K in Q2 2015. 1,053 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Miles Capital held 1,944 shares of Elevance Health worth $441K as of Q1 2020.
  • Miles Capital bought 47 Elevance Health shares in Q1 2020, an estimated $12.8K.
  • Elevance Health made up 0.48% of Miles Capital's portfolio in Q1 2020, its #59 holding.
  • Miles Capital first reported a position in Elevance Health in Q1 2015 and has held it in 6 quarters since.
  • Miles Capital's Elevance Health position peaked at $979K in Q2 2015.
  • 1,053 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.